AIM's Iterative Process High-Efficiency Diploid Rabies Vaccine Completes Phase III Clinical Trials, Efficacy Significantly Higher than Existing Market Products

AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully ...
Forbes

Under RFK Jr., Vaccine Development Is Facing Unprecedented Challenges

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...
STAT

U.S. health officials inject new uncertainty into approval process for Covid boosters

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
MarketWatch

POP BIO and CEPI announce collaboration for faster responses to Disease X

The MarketWatch News Department was not involved in the creation of this content. Buffalo, NY, July 25, 2025 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a biotechnology company specializing in ...
National Academies of Sciences%2c Engineering%2c and Medicine

The Search for a COVID-19 Vaccine — ‘There’s No One Winner’

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
STAT

When it comes to vaccine schedules, the U.S. is now the outlier

In fact, the pared-down U.S. vaccine schedule now aims to protect children against fewer diseases than all but one of the 20 ...
NewsNation on MSN

Cedar fever cure? Researchers developing vaccine for severe allergies

Researchers at Penn Medicine have developed an mRNA vaccine that could potentially cure allergies by stopping allergens from ...